Post-Conference Perspectives: Urothelial Carcinoma 2022 Year in Review - Episode 7

Metastatic Urothelial Carcinoma Treatment after Disease Progression on Avelumab

,

Key opinion leaders discuss the best treatment approaches for urothelial carcinoma after avelumab failure.

EP. 1: Incidence and Risk Factors for Urothelial Carcinoma
EP. 2: Neoadjuvant Chemotherapy as Standard-of-Care for Muscle-Invasive Urothelial Carcinoma
EP. 3: Neoadjuvant Chemotherapy in Urothelial Carcinoma: The CHECKMATE-274 Trial
EP. 4: Neoadjuvant Chemotherapy in Urothelial Carcinoma: The IMvigor010 Study
EP. 5: Treatment Options for Frontline Metastatic Urothelial Carcinoma
EP. 6: Outcomes of the JAVELIN Bladder 100 Trial
Now Viewing
EP. 7: Metastatic Urothelial Carcinoma Treatment after Disease Progression on Avelumab
EP. 8: Key Trial Data in Urothelial Carcinoma Treatment from ESMO 2022